
Cardiol Therapeutics Inc
NASDAQ:CRDL

Intrinsic Value
The intrinsic value of one
CRDL
stock under the Base Case scenario is
0.55
USD.
Compared to the current market price of 1.12 USD,
Cardiol Therapeutics Inc
is
Overvalued by 51%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cardiol Therapeutics Inc
Fundamental Analysis
Want a deep‑dive on Cardiol Therapeutics Inc?
Request it below and we’ll move it up the queue.

Revenue & Expenses Breakdown
Cardiol Therapeutics Inc
Balance Sheet Decomposition
Cardiol Therapeutics Inc
Current Assets | 17.3m |
Cash & Short-Term Investments | 15.9m |
Receivables | 266.7k |
Other Current Assets | 1.1m |
Non-Current Assets | 238k |
PP&E | 237.9k |
Other Non-Current Assets | 100 |
Free Cash Flow Analysis
Cardiol Therapeutics Inc
CAD | |
Free Cash Flow | CAD |
Earnings Waterfall
Cardiol Therapeutics Inc
Revenue
|
0
CAD
|
Operating Expenses
|
-38.3m
CAD
|
Operating Income
|
-38.3m
CAD
|
Other Expenses
|
2.2m
CAD
|
Net Income
|
-36.1m
CAD
|
CRDL Profitability Score
Profitability Due Diligence
Cardiol Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Score
Cardiol Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
CRDL Solvency Score
Solvency Due Diligence
Cardiol Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
Cardiol Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRDL Price Targets Summary
Cardiol Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CRDL
is 6.89 USD
with a low forecast of 5.94 USD and a high forecast of 8 USD.
Dividends
Current shareholder yield for CRDL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRDL
stock under the Base Case scenario is
0.55
USD.
Compared to the current market price of 1.12 USD,
Cardiol Therapeutics Inc
is
Overvalued by 51%.